1. Home
  2. AXGN

as 03-28-2025 4:00pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Electromedical & Electrotherapeutic Apparatus

Nasdaq

Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.

Founded: N/A Country:
United States
United States
Employees: N/A City: ALACHUA
Market Cap: 887.3M IPO Year: N/A
Target Price: $24.17 AVG Volume (30 days): 556.8K
Analyst Decision: Strong Buy Number of Analysts: 6
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.23 EPS Growth: N/A
52 Week Low/High: $5.55 - $21.00 Next Earning Date: 05-01-2025
Revenue: $187,338,000 Revenue Growth: 17.81%
Revenue Growth (this year): 18.2% Revenue Growth (next year): 16.48%

AXGN Daily Stock ML Predictions

Stock Insider Trading Activity of Axogen Inc. (AXGN)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
DeVinney Erick Wayne AXGN Chief Innovation Officer Mar 16 '25 Sell $17.50 15,111 $264,442.50 217,762
Wendell Amy McBride AXGN Director Mar 3 '25 Sell $20.02 5,000 $100,100.00 97,899

Share on Social Networks: